Similar to genetic or pharmacological inhibition of CARM1 and ablation of NFIB methylation, we observed reduced tumorigenic capacity of SCLC cells upon TRIM29 deletion (Supplementary Fig. 3f, g). The gene discussed is NFIB; the disease is small cell lung carcinoma.